Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab plus azathioprine versus azathioprine alone for membranous lupus nephritis
2005-004067-30Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Mar 2006
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic lupus erythematosus (SLE) and lupus nephritis (LN) comparing Remicade plus azathioprine with Placebo plus azathioprine (2 arms). Primary endpoint: Key efficacy objective. Started Mar 2006; status: terminated.
02
Drugs
infliximabazathioprine
03
Conditions
systemic lupus erythematosus (SLE)lupus nephritis (LN)
Beyond the preview
Go deeper on 2005-004067-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004067-30.